COVID-19 VACCINE 2023-2024 CPT Vaccine Code: 91318
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 3 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use
Vaccine & Product Overview
About COVID-19 VACCINE 2023-2024
Covid-19 Vaccine 2023-2024 is a medication aligned to the HCPCS CPT Drug Code: 91318 for billing, pricing, and reimbursement purposes in the United States. Classified under COVID-19, it is administered via the intramuscular route and manufactured by Pfizer.
According to CMS Drug Use Information: This vaccine is used to help prevent coronavirus disease, also known as COVID-19. It works by increasing the body's natural defense (immunity) against the virus. This vaccine may prevent the illness, or reduce the seriousness of it. Vaccines may not fully protect everyone who receives them.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
1 NDC package is crosswalked to 91318. Package detail is available to logged-in subscribers.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| •••••-••••-•• Log in to view | COVID-19 VACCINE 2023-2024 | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
COVID-19 VACCINE 2023-2024 Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →
COVID-19 VACCINE 2023-2024 Vaccine Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid) |
| 90472 | Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure. |
COVID-19 VACCINE 2023-2024 Medically Unlikely Edits (MUE)
The most billing units of 91318 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.3 ml.
MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →
COVID-19 VACCINE 2023-2024 Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there a manufacturer-published billing and coding guide for Covid-19 Vaccine 2023-2024?
Are there any available patient assistance programs for Covid-19 Vaccine 2023-2024?
Where can I find Covid-19 Vaccine 2023-2024 prescribing information?
Is there available side effect information for Covid-19 Vaccine 2023-2024?
Does billing COVID-19 VACCINE 2023-2024 require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to COVID-19 VACCINE 2023-2024.
